| estrogen receptors, 188-89, 191-92, 207, 247-48
|
| generated in ovulatory cycle, 167-68, 187
|
| global consumption of, 186-92
|
| isolation of and research on, 183-84
|
| male vs. female levels of, 185
|
| phytoestrogens, 181, 212
|
| post-pregnancy, 148
|
| replacement therapy, 60, 184, 185, 231, 233
|
| for AlS, 32
|
| and blood clots, 189
|
| debate over, 185, 207-15
|
| medical promotion of, 220
|
| resistance to, 191
|
|